New Zealand markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
198.79+8.78 (+4.62%)
As of 10:04AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 9.66B
Enterprise value 12.88B
Trailing P/E 22.07
Forward P/E 14.60
PEG ratio (5-yr expected) 0.96
Price/sales (ttm)2.65
Price/book (mrq)3.65
Enterprise value/revenue 3.49
Enterprise value/EBITDA 14.79

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 3-54.40%
S&P500 52-week change 3-16.45%
52-week high 3449.34
52-week low 3181.36
50-day moving average 3214.71
200-day moving average 3263.29

Share statistics

Avg vol (3-month) 3546.11k
Avg vol (10-day) 3595.72k
Shares outstanding 550.86M
Implied shares outstanding 6N/A
Float 850.31M
% held by insiders 11.01%
% held by institutions 197.54%
Shares short (30 Aug 2022) 41.01M
Short ratio (30 Aug 2022) 41.62
Short % of float (30 Aug 2022) 42.57%
Short % of shares outstanding (30 Aug 2022) 41.99%
Shares short (prior month 28 Jul 2022) 4976.91k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 24 Dec 2021
Most-recent quarter (mrq)24 Jun 2022

Profitability

Profit margin 12.02%
Operating margin (ttm)18.91%

Management effectiveness

Return on assets (ttm)6.12%
Return on equity (ttm)17.87%

Income statement

Revenue (ttm)3.69B
Revenue per share (ttm)72.90
Quarterly revenue growth (yoy)6.40%
Gross profit (ttm)1.34B
EBITDA 985.1M
Net income avi to common (ttm)443.35M
Diluted EPS (ttm)8.73
Quarterly earnings growth (yoy)23.60%

Balance sheet

Total cash (mrq)201.33M
Total cash per share (mrq)3.96
Total debt (mrq)3.41B
Total debt/equity (mrq)126.78
Current ratio (mrq)1.33
Book value per share (mrq)52.06

Cash flow statement

Operating cash flow (ttm)656.08M
Levered free cash flow (ttm)405.11M